Presenter's Information
Davide Francesco Maria Capodanno, MD
| Country | Italy |
| Specialty | Interventional Cardiologist |
- Is IL-6 a Possible Target to Prevent Post-AMI Cardiovascular Events?
- Management of Acute Coronary Syndrome Patient With Multivessel Disease
- Modulation of Antiplatelet Therapy After PCI: Balancing Ischemia and Bleeding
- The Clinical Syndrome of Transcatheter Valve Thrombosis: Diagnosis and Management
- Novel Lipoprotein (a) Inhibitor in ACS/PCI
- Next Novel Antithrombotic Agents in ACS/PCI: Factor XIa Inhibitor and More
- Escalation Antithrombotic Strategy: When and How?
- Short DAPT Followed by P2Y12 Monotherapy: New Trend Updates with Clinical Evidences
- Optimal Antithrombotics for Complex Patients: Different Drugs, Dosing, or Duration?
- Atrial Fibrillation and ACS/PCI: Chains of RCTs up to AUGUSTUS - Enough Evidence or More?
- Durability of Transcatheter Aortic Valves: An Update
- Rethinking DAPT Duration with Smarter DES: Personalized vs. Generalized Strategy
- Multivessel PCI in AMI and Cardiogenic Shock: SHOCK Trial Series Review and Real-World Application
- DAPT After BRS Implantation: The Longer the Better?
- Updated BRS Data; Trials and Registries
- A Multicenter Registry Evaluating New Generation Drug-Eluting Stents in Patients with Obstructive Left Main Coronary Artery Disease: DELTA II
- BRS for Complex Lesions; Share the Experience
- Is BRS Safe?
- PCI vs. CABG in LM PCI - Where Are We in 2017?
- Contemporary Practice and Technical Aspects in PCI with BRS: A European Perspective
- Should Bioresorbable Scaffold(BRS) Be Used in STEMI?
- New Insights with Bioresorbable Scaffolds
- Choosing LM Treatment and Predicting Outcomes Using Clinical, Anatomic or New Scores
- Stent Thrombosis Risk After BRS
- Stent Thrombosis After BMS, DES and BRS for Bifurcations
